Spedizione gratuita per ordini superiori a 69,99 euro.

Controllare lo stato dell'ordine

Entra a far parte di una comunità di amanti dei libri di tutto il mondo e ottieni numerosi vantaggi. Crea un account gratuito

Spedizione gratuita con Packeta per un prezzo superiore a 69.99 €

Corriere Bartolini 4.49 € Punto Poste 5.49 € Punto Poste 5.49 € Punto Bartolini 3.49 € Corriere DHL 6.99 € Corriere GLS 5.99 € Punto GLS 4.49 €

Contatto

Come acquistare

Aiuto

Il mio account

▸ Vuoto :-(

Spedizione gratuita per ordini superiori a 69,99 euro.

Lung Cancer

Name: Lung Cancer
Brand: Springer, Berlin
SKU: 41526969
Price: 117.99 EUR
Availability: InStock
Author: Anne C. Chiang
ISBN: 9783030740306

New Understandings and Therapies

Anne C. Chiang

Roy S. Herbst

Lingua

Inglese

Libro In brossura

Codice Libristo: 41526969

Casa editrice Springer, Berlin, novembre 2021

Lung cancer has seen a paradigm shift in disease treatment over the past few years, with major chang... Descrizione completa

Codice Libristo: 41526969

289 b

117.99 €

Magazzino esterno Inviamo tra 5-8 giorni

Fino a 30 giorni per il reso

I clienti hanno acquistato anche

In die Wildnis Jon Krakauer

In brossura

11.39 €

Gecko Run, Snake

Gioco

13.89 €

Neuvědomovaný Bůh Viktor Emil Frankl

Libro

5.79 €

Le Mercenaire - Intégrale Tome 02 Vicente Segrelles

Rigido

46.29 €

To Wong Foo, Thanks for everything Julie Newmar, DVD, DVD-Video Douglas Carter Beane

DVD

11.39 €

Goethe's Leben J. W. Schaefer

In brossura

46.69 €

Vvedenie V Meditsinskuyu Parazitologiyu Sergey Kostyukevich

In brossura

51.99 €

Sailor Moon T08

In brossura

11.29 €

Arsene lupin - le bouchon de cristal Leblanc Maurice Libro

In brossura

9.39 €

La noche de Nandi EILEEN BROWNE

Rigido

20.39 €

Unentbehrliche Begleiter Nach Und Auf Helgoland Sigismund Wallace

In brossura

27.99 €

Alfred Mende - Ein Freiberger Original Frank Löser

In brossura

13.39 €

Sankt Martinsfest. Kamishibai Bildkartenset. Esther Hebert

Gioco

18.19 €

Thelema 6 Behemoth

CD audio

11.79 €

Lung cancer has seen a paradigm shift in disease treatment over the past few years, with major changes in the therapeutic drugs now available as well as in the overall management approach. For targeted and immunotherapeutic approaches, understanding the biology of acquired resistance is a key strategy that has yielded productive advances in the subsequent treatment. Future advances also include incorporating biomarker data obtained from solid and liquid biopsies, as well as combination of immunotherapy with radiotherapy and in special populations such patients with CNS involvement.